Category: Diseases & Conditions
Global Diseases & Conditions
-
Global Drugs for Malaria Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The ... Read More
-
Global Digital Diabetes Management Databank Market Report
... 2023 to 2031. Continuous Blood Glucose Monitoring System segment is expected to be the highest contributor to this market, with $4,876.9 Million in 2022, and is anticipated to reach $9,140.7 Million by 2031, registering a ... Read More
-
Global Castrate-resistant Prostate Cancer Databank Market Report
... 2023 to 2031. Hormonal Therapy segment is expected to be the highest contributor to this market, with $7,227.4 Million in 2022, and is anticipated to reach $12,564.7 Million by 2031, registering a CAGR of 6.39%. ... Read More
-
Global Insomnia Therapeutics Databank Market Report
... 2031. Drugs segment is expected to be the highest contributor to this market, with $3,103.4 Million in 2022, and is anticipated to reach $4,664.6 Million by 2031, registering a CAGR of 4.67%. Medical Devices segment ... Read More
-
Global Multiple Sclerosis Therapeutics Databank Market Report
... 2021 to 2029. Small-molecule Drugs segment is expected to be the highest contributor to this market, with $6,472.6 Million in 2020, and is anticipated to reach $12,240.1 Million by 2029, registering a CAGR of 7.38%. ... Read More
-
Global Cancer Registry Software Databank Market Report
... from 2023 to 2031. Integrated segment is expected to be the highest contributor to this market, with $35.1 Million in 2022, and is anticipated to reach $42.9 Million by 2031, registering a CAGR of 2.28%. Read More
-
Global Analgesic Infusion Pumps Databank Market Report
... 2023 to 2031. Patient-Controlled Analgesia Pump segment is expected to be the highest contributor to this market, with $5,519.1 Million in 2022, and is anticipated to reach $13,717.3 Million by 2031, registering a CAGR of ... Read More
-
Global Liver Cancer Drugs Databank Market Report
... 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $1,442.5 Million in 2022, and is anticipated to reach $4,029.6 Million by 2031, registering a CAGR of 12.16%. ... Read More
-
Medical Tourism Market - By Application (Cosmetic Surgery {Hair Transplant, Breast Augmentation}, Cardiovascular Surgery, Orthopedic Surgery, Oncology Treatment, Dental Surgery, Bariatric Surgery, Fertility Treatment) & Forecast 2024 - 2032
... 16.3% CAGR between 2024 and 2032, driven by rising collaborations between leading facility providers. These partnerships are crucial in enhancing the overall patient experience, offering comprehensive healthcare packages that include advanced medical treatments, post-operative care, ... Read More
-
Biomarkers Market by Product & Service (Consumable, Software), Type (Safety, Efficacy), Research Area, Technology (NGS, PCR, Mass Spectrometry), Disease (Cancer, Infectious), Application (Diagnostics, Clinical Research) - Global Forecast to 2029
... to reach USD 93.8 billion in 2029 from USD 57.7 billion in 2024, at a CAGR of 10.2% during the forecast period. The growth of this market can be attributed to the advantage that these ... Read More
-
Global Hepatitis A Vaccine Market Analysis and Forecast 2024-2030
... age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally" 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric ... Read More
-
Global Hepatitis A Vaccine Market Size, Manufacturers, Opportunities and Forecast to 2030
... HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are ... Read More
-
Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2024
... scenario. This report provides top line data relating to the clinical trials on Chronic Lymphocytic Leukemia (CLL). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ... Read More
-
Mycosis Fungoides - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Mycosis Fungoides. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Global Tuberculosis (TB) Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, ... Read More
-
Epilepsy - Global Clinical Trials Review, 2024
... the clinical trials on Epilepsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 ... Read More
-
Pulmonary Tuberculosis - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Pulmonary Tuberculosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Global Tuberculosis (TB) Diagnostics Market Analysis and Forecast 2024-2030
... the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those ... Read More
-
Global Tuberculosis (TB) Diagnostics Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills ... Read More
-
Global Syphilis Rapid Test Kit Market Size, Manufacturers, Opportunities and Forecast to 2030
... anal sex. Congenital syphilis is the name given to syphilis that is spread from a mother who has the disease to her baby during childbirth, which can cause severe abnormalities or death of the baby. ... Read More
-
Global Hepatitis A Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. ... Read More
-
Vaccines Market by Technology (Conjugate, Recombinant, Live Attenuated, Toxoid, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, HPV, Herpes Zoster, MMR, Rotavirus, RSV), Route of Administration - Global Forecast to 2029
... (including COVID-19 vaccines) is projected to reach USD 94.9 Billion by 2029 from USD 78.0 Billion in 2024, at a CAGR of 4.0% during the forecast period. Similarly the vaccines market (excluding COVID-19 vaccines) is ... Read More
-
Global Syphilis Rapid Test Kit Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... contact, including oral, vaginal, and anal sex. Congenital syphilis is the name given to syphilis that is spread from a mother who has the disease to her baby during childbirth, which can cause severe abnormalities ... Read More
-
Global Hepatitis A Vaccine Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines ... Read More
-
Global Hemophilia Gene Therapy Market Analysis and Forecast 2024-2030
... genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. Individuals ... Read More
Research Assistance
